(Q37725083)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

The Asia-Pacific consensus on ulcerative colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Wai Keung Leung

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Rupert W. Leong

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sathaporn Manatsathit

13

object named as

Sathaporn Manatsathit

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

12

Jose Sollano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

6

Ida Hilmi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Choon Jin Ooi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Kwong Ming Fock

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Govind K Makharia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Khean Lee Goh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Khoon Lin Ling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Wee Chian Lim

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Thia Kelvin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Peter R Gibson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Qin Ouyang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Rungsun Rerknimitr

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Shu-Chen Wei

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

H Janaka de Silva

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Asia Pacific Association of Gastroenterology Working Group on Inflammatory Bowel Disease

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

1 reference

1 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

453-468

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370724%20AND%20SRC:MED&resulttype=core&format=json

Management consensus of inflammatory bowel disease for the Asia-Pacific region

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Infectious colitis endoscopically simulating inflammatory bowel disease: a prospective evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Campylobacter jejuni pancolitis mimicking idiopathic ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Ulcerative post-dysenteric colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Ulcerative colitis developing after amoebic dysentery in a haemophiliac patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Observer variation and discriminatory value of biopsy features in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Patterns of colonic involvement at initial presentation in ulcerative colitis: a retrospective study of 46 newly diagnosed cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Anti-neutrophil cytoplasmic antibodies (ANCA) and inflammatory bowel diseases in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Clinical features and natural history of ulcerative colitis in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Ulcerative ileitis encountered at ileo-colonoscopy: likely role of nonsteroidal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Definition of megacolon in colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Clinical characteristics of ulcerative colitis in Singapore, a multiracial city-state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Inflammatory bowel disease: a survey of the epidemiology in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

An update on the epidemiology of inflammatory bowel disease in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Epidemiology of inflammatory bowel disease in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Incidence and prevalence of ulcerative colitis in Punjab, North India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Association of HLA class-II genes and anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Familial occurrence of inflammatory bowel disease in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Management of extraintestinal manifestations and other complications of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Risk of colorectal cancer in ulcerative colitis in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Trends of ulcerative colitis-associated colorectal cancer in Korea: A KASID study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Review article: aminosalicylates for distal colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Intensive intravenous regimen for severe attacks of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Further experience in the treatment of severe attacks of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Review article: medical treatment of severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Ciclosporin use in acute ulcerative colitis: a long-term experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Leukocytapheresis for the treatment of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Use of antibiotics in the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A district general hospital experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Exposing the weaknesses: a systematic review of azathioprine efficacy in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

The efficacy of methotrexate for maintaining remission in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Response of refractory colitis to intravenous or oral tacrolimus (FK506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Male infertility due to sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Enteral nutrition in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06241.X